Howard R. Yeaton
2020
In 2020, Howard R. Yeaton earned a total compensation of $240.4K as Former Chief Executive Officer and Interim Chief Financial Officer at Akers Biosciences, a 29% decrease compared to previous year.
Compensation breakdown
| Salary | $228,386 |
|---|---|
| Other | $12,000 |
| Total | $240,386 |
Yeaton received $228.4K in salary, accounting for 95% of the total pay in 2020.
Yeaton also received $12K in other compensation.
Rankings
In 2020, Howard R. Yeaton's compensation ranked 12,417th out of 13,090 executives tracked by ExecPay. In other words, Yeaton earned more than 5.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,417 out of 13,090 | 5th |
Division Manufacturing | 5,327 out of 5,624 | 5th |
Major group Chemicals And Allied Products | 2,157 out of 2,257 | 4th |
Industry group Drugs | 1,875 out of 1,957 | 4th |
Industry In Vitro and In Vivo Diagnostic Substances | 57 out of 60 | 5th |
Source: SEC filing on November 22, 2021.
Yeaton's colleagues
We found four more compensation records of executives who worked with Howard R. Yeaton at Akers Biosciences in 2020.